Osteoprotegerin/Receptor Activator of Nuclear Factor-Kappa B Ligand/Receptor Activator of Nuclear Factor-Kappa B Axis in Obesity, Type 2 Diabetes Mellitus, and Nonalcoholic Fatty Liver Disease

PURPOSE OF REVIEW: To summarize evidence on the potential involvement of the osteoprotegerin (OPG)/receptor activator of nuclear factor-kappa B (NF-κΒ) ligand (RANKL)/receptor activator of NF-κΒ (RANK) axis in the pathogenesis of metabolic diseases. RECENT FINDINGS: The OPG-RANKL-RANK axis, which ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Vachliotis, Ilias D., Polyzos, Stergios A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250495/
https://www.ncbi.nlm.nih.gov/pubmed/37208545
http://dx.doi.org/10.1007/s13679-023-00505-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250495/
https://www.ncbi.nlm.nih.gov/pubmed/37208545
http://dx.doi.org/10.1007/s13679-023-00505-4

Ejemplares similares